TIEKF yields 1.95% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, TIEKF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TIEKF + MRK for your $10,000?
TIE Kinetix N.V. develops, distributes, and sells software and services in the Netherlands, the United States, Germany, and France. The company offers digital supply chain solutions; and electronic document exchange solutions, such as electronic data interchange (EDI)-2-FLOW, PDF-2-FLOW, and PORTAL-2-FLOW, as well as E-Archiving. It also provides software as a service solution for exchanging business documents to companies, governmental institutions, and trading partners and suppliers, as well as artificial intelligence-powered onboarding services. In addition, the company offers AP automation solutions for buyers and suppliers to engage in smart business exchanges; pre-built connectors and standardized API integrations to connect to ERP or other systems; compliance solutions; value added network services, which enables trading partners to communicate and exchange business documents in various formats real-time using various communication protocols; electronic invoicing solutions; and consultancy services. Further, it provides FLOW Partner Automation platform that combines supply chain integration solutions, such as EDI/XML, PDF conversion, and supplier portal, as well as analytics data and dashboards for users. The company offers its solutions to business services, industry and home improvement, telecom, banking and insurance, food industry and food retail, non-food, consumer electronics, transport and logistics, office supplies, automotive, medical, and others markets directly, as well as through a network of distribution partners. TIE Kinetix N.V. was founded in 1987 and is headquartered in Breukelen, the Netherlands.
Full TIEKF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.